Drreddys Laboratories | RDY - Lucro Operacional





Lucro Operacional Alterar Data
ANI Pharmaceuticals USD 51.84M 12M 2026-09
Aurora Cannabis CAD -8.73M 1.3M 2026-06
Bayer EUR 129M 698M 2026-09
Canopy Growth CAD -17.58M 9.9M 2026-06
Cipla INR 10.43B 1.55B 2026-09
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Drreddys Laboratories INR 12.81B 11.98B 2026-09
GlaxoSmithKline GBP 2.86B 251M 2026-09
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Novartis USD 5.14B 392M 2026-09
Pacira USD 2.57B 2.56B 2026-09
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Richter Gedeon HUF 76.16B 13.84B 2026-06
Sun Pharmaceuticals INR 39.07B 3.5B 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09